Analyst Ranking
Bottom 1%
#4097 out of 4117 analysts
Average Return
Win Rate
6%1 out of 17
Risk vs Reward

Steven Mah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
23andme Holding CoME
2022-09-21 -

Steven Mah's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
23andme Holding CoME
1Buy$6.00+109.06%Initiates Coverage On
2 months ago
Absci CorpABSI
3 months ago
Codexis IncCDXS
4 months ago
Ginkgo Bioworks Holdings IncDNA
1Buy$12.00+503.02%Initiates Coverage On
9 months ago
Talis Biomedical CorpTLIS
a year ago
Heska CorpHSKA
2Strong Buy$305.00N/AMaintains
a year ago
Natera IncNTRA
2Strong Buy$155.00N/AMaintains
a year ago
Akoya Biosciences IncAKYA
1Strong Buy$28.00N/AInitiates Coverage On
2 years ago
Luminex CorpLMNX
2 years ago
Twist Bioscience CorpTWST
1Strong Buy$150.00N/AInitiates Coverage On
2 years ago
Fulgent Genetics IncFLGT
1Strong Buy$140.00N/AMaintains
2 years ago
Ortho Clinical Diagnostics Holdings PLCOCDX
1Strong Buy$27.00N/AInitiates Coverage On
2 years ago
Pacific Biosciences Of California IncPACB
1Strong Buy$52.00N/AUpgrades
2 years ago
Oxford Immunotec Global PLCOXFD
2 years ago
Oncocyte CorpOCX
1Strong Buy$4.00N/AUpgrades
2 years ago
Illumina IncILMN
2 years ago
Quidelortho CorpQDEL
1Strong Buy$250.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.